tenk.fyi

Outlook Therapeutics, Inc.

OTLKNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.4M

Net Income

-$62.4M

17.2% YoY

EPS

$-1.79

55.9% YoY

Cash

$8.1M

45.9% YoY

FY 2025 · As of 2025-09-30

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade